Seven Years of Clinical Experience Outcome Review on Radium 223 Therapy In Bone Metastatic Castrate-resistant Prostate Cancer (mCRPC)

被引：0
|
作者：
Cantinho-Lopes, M. [1 ]
Pena, H. [1 ]
Filipe, P. [2 ]
Mansinho, A. [2 ]
Fernandes, I. [2 ]
Costa, L. [2 ]
机构：
[1] Fac Med Lisbon, Inst Med Nucl, Lisbon, Portugal
[2] CHULN, S Oncol, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-225
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [21] A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
    Charrois-Durand, Cedric
    Saad, Fred
    Barkati, Maroie
    Lattouf, Jean-Baptiste
    Perrotte, Paul
    Karakiewicz, Pierre, I
    Soulieres, Denis
    Blais, Normand
    Hamilou, Zineb
    Juneau, Daniel
    Plouznikoff, Nicolas
    Taussky, Daniel
    Delouya, Guila
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (06): : 199 - 205
  • [22] To assess the clinical effect of radium 223 (Ra223) in patients with progressive symptomatic bone metastases on a background of metastatic castrate resistant prostate cancer (mCRPC).
    Hague, Christina J.
    Fisher, Charlotte
    Wylie, James
    Choudhury, Ananya
    Elliot, Tony
    Tran, Anna
    Coyle, Catherine
    Conroy, Ruth
    Logue, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [23] Outcomes with Radium-223 therapy in clinical practice of metastatic castration resistant prostate cancer (mCRPC).
    Alva, Ajjai Shivaram
    Nordquist, Luke T.
    Daignault, Stephanie
    George, Saby
    Ramos, Jorge
    Isharwal, Sudhir
    McDonald, Matthew
    Campbell, Gregory
    Danchaivijitr, Pongwut
    Albany, Costantine
    Yu, Evan Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] A phase Ib trial to study the safety and tolerability of atezolizumab with radium-223 dichloride in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Fong, Lawrence
    Morris, Michael
    Armstrong, Andrew
    Petrylak, Daniel
    Vaishampayan, Ulka
    Alva, Ajjai
    Hoffman-Censits, Jean
    Sarkar, Indrani
    Carroll, Susheela
    Schiff, Christina
    Sartor, Oliver
    CANCER RESEARCH, 2017, 77
  • [25] Radium 223 Therapy in Symptomatic Metastatic Castrate Resistant Prostate Cancer - Newcastle Experience: a Quality of Life Issue
    Jiang, X. Y.
    Atkinson, S.
    Frew, J.
    McMenemin, R.
    Leaning, D.
    Pedley, I.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 194 - 194
  • [26] Use of radium-223 in heavily pretreated metastatic castrate resistant prostate cancer (mCRPC) patients.
    Modi, Dipenkumar
    Kim, SeongHo
    Mamdani, Hirva Mansurali
    Hwang, Clara
    Gayar, Hersham
    Vaishampayan, Ulka N.
    Joyrich, Richard
    Heath, Elisabeth I.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [27] CABAZITAXEL IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC): AUSTRALIAN CLINICAL EXPERIENCE
    Gurney, H.
    Ng, S.
    Parente, P.
    Bahre, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 36 - 37
  • [28] Radium-223 in Metastatic Castration Resistant Prostate Cancer (mCRPC): a Single Cancer Centre Experience
    Tsoukalas, N.
    Morgui, M. Saigi
    Mills, C.
    Lewington, V.
    Chowdhury, S.
    Rudman, S.
    CLINICAL ONCOLOGY, 2016, 28 (05) : E15 - E15
  • [29] Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Quinn, Zachary
    Leiby, Benjamin
    Sonpavde, Guru
    Choudhury, Atish D.
    Sweeney, Christopher
    Einstein, David
    Szmulewitz, Russell
    Sartor, Oliver
    Knudsen, Karen
    Yang, Eddy Shih-Hsin
    Kelly, Wm. Kevin
    CLINICAL CANCER RESEARCH, 2023, 29 (01) : 50 - 59
  • [30] Exosomal microRNA as prognostic biomarkers in metastatic castrate-resistant prostate cancer (mCRPC).
    Kohli, Manish
    Huang, Xiaoyi
    Yuan, Tiezheng
    Sun, Zhifu
    Costello, Brian Addis
    Quevedo, Fernando
    Tan, Winston
    Nandy, Debashis
    Longenbach, Sherri
    Wang, Liang
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
12345